vs
Side-by-side financial comparison of LivaNova PLC (LIVN) and Cloudflare, Inc. (NET). Click either name above to swap in a different company.
Cloudflare, Inc. is the larger business by last-quarter revenue ($614.5M vs $360.9M, roughly 1.7× LivaNova PLC). LivaNova PLC runs the higher net margin — 8.6% vs -2.0%, a 10.5% gap on every dollar of revenue. On growth, Cloudflare, Inc. posted the faster year-over-year revenue change (33.6% vs 12.1%). Cloudflare, Inc. produced more free cash flow last quarter ($105.2M vs $50.2M). Over the past eight quarters, Cloudflare, Inc.'s revenue compounded faster (27.4% CAGR vs 10.6%).
LivaNova, plc is an American medical device manufacturer based in the UK. The company develops devices used for cardiac surgery and neuromodulation. The company was formed in 2015 by a $2.7B merger between Houston, Texas-based Cyberonics, Inc. and Milan, Italy-based Sorin S.p.a. The company trades on the NASDAQ stock exchange under the ticker symbol "LIVN".
Cloudflare, Inc. is an American technology company headquartered in San Francisco, California, that provides a range of internet services, including content delivery network (CDN) services, cloud cybersecurity, DDoS mitigation, and ICANN-accredited domain registration. The company's services act primarily as a reverse proxy between website visitors and a customer's hosting provider, improving performance and protecting against malicious traffic.
LIVN vs NET — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $360.9M | $614.5M |
| Net Profit | $30.9M | $-12.1M |
| Gross Margin | 65.2% | 73.6% |
| Operating Margin | 11.8% | -8.0% |
| Net Margin | 8.6% | -2.0% |
| Revenue YoY | 12.1% | 33.6% |
| Net Profit YoY | -44.7% | 6.0% |
| EPS (diluted) | $0.57 | $-0.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $360.9M | $614.5M | ||
| Q3 25 | $357.8M | $562.0M | ||
| Q2 25 | $352.5M | $512.3M | ||
| Q1 25 | $316.9M | $479.1M | ||
| Q4 24 | $321.8M | $459.9M | ||
| Q3 24 | $318.1M | $430.1M | ||
| Q2 24 | $318.6M | $401.0M | ||
| Q1 24 | $294.9M | $378.6M |
| Q4 25 | $30.9M | $-12.1M | ||
| Q3 25 | $26.8M | $-1.3M | ||
| Q2 25 | $27.2M | $-50.4M | ||
| Q1 25 | $-327.3M | $-38.5M | ||
| Q4 24 | $55.9M | $-12.8M | ||
| Q3 24 | $33.0M | $-15.3M | ||
| Q2 24 | $16.3M | $-15.1M | ||
| Q1 24 | $-41.9M | $-35.5M |
| Q4 25 | 65.2% | 73.6% | ||
| Q3 25 | 68.4% | 74.0% | ||
| Q2 25 | 67.8% | 74.9% | ||
| Q1 25 | 69.7% | 75.9% | ||
| Q4 24 | 68.2% | 76.4% | ||
| Q3 24 | 70.8% | 77.7% | ||
| Q2 24 | 68.7% | 77.8% | ||
| Q1 24 | 70.3% | 77.5% |
| Q4 25 | 11.8% | -8.0% | ||
| Q3 25 | 15.1% | -6.7% | ||
| Q2 25 | 15.4% | -13.1% | ||
| Q1 25 | 15.3% | -11.1% | ||
| Q4 24 | 11.5% | -7.5% | ||
| Q3 24 | 11.2% | -7.2% | ||
| Q2 24 | 12.6% | -8.7% | ||
| Q1 24 | 5.5% | -14.4% |
| Q4 25 | 8.6% | -2.0% | ||
| Q3 25 | 7.5% | -0.2% | ||
| Q2 25 | 7.7% | -9.8% | ||
| Q1 25 | -103.3% | -8.0% | ||
| Q4 24 | 17.4% | -2.8% | ||
| Q3 24 | 10.4% | -3.6% | ||
| Q2 24 | 5.1% | -3.8% | ||
| Q1 24 | -14.2% | -9.4% |
| Q4 25 | $0.57 | $-0.03 | ||
| Q3 25 | $0.49 | $0.00 | ||
| Q2 25 | $0.50 | $-0.15 | ||
| Q1 25 | $-6.01 | $-0.11 | ||
| Q4 24 | $1.04 | $-0.05 | ||
| Q3 24 | $0.60 | $-0.04 | ||
| Q2 24 | $0.30 | $-0.04 | ||
| Q1 24 | $-0.78 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $635.6M | $943.5M |
| Total DebtLower is stronger | $376.1M | — |
| Stockholders' EquityBook value | $1.2B | $1.5B |
| Total Assets | $2.6B | $6.0B |
| Debt / EquityLower = less leverage | 0.31× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $635.6M | $943.5M | ||
| Q3 25 | $646.1M | $1.1B | ||
| Q2 25 | $593.6M | $1.5B | ||
| Q1 25 | $738.4M | $204.5M | ||
| Q4 24 | $428.9M | $147.7M | ||
| Q3 24 | $346.4M | $182.9M | ||
| Q2 24 | $329.2M | $157.0M | ||
| Q1 24 | $309.2M | $254.4M |
| Q4 25 | $376.1M | — | ||
| Q3 25 | $434.5M | — | ||
| Q2 25 | $430.6M | — | ||
| Q1 25 | $628.2M | — | ||
| Q4 24 | $627.0M | — | ||
| Q3 24 | $625.5M | — | ||
| Q2 24 | $624.5M | — | ||
| Q1 24 | $623.8M | — |
| Q4 25 | $1.2B | $1.5B | ||
| Q3 25 | $1.2B | $1.3B | ||
| Q2 25 | $1.1B | $1.2B | ||
| Q1 25 | $1.0B | $1.4B | ||
| Q4 24 | $1.3B | $1.0B | ||
| Q3 24 | $1.3B | $973.1M | ||
| Q2 24 | $1.2B | $881.5M | ||
| Q1 24 | $1.2B | $797.2M |
| Q4 25 | $2.6B | $6.0B | ||
| Q3 25 | $2.6B | $5.8B | ||
| Q2 25 | $2.5B | $5.6B | ||
| Q1 25 | $2.6B | $3.7B | ||
| Q4 24 | $2.5B | $3.3B | ||
| Q3 24 | $2.5B | $3.1B | ||
| Q2 24 | $2.5B | $2.9B | ||
| Q1 24 | $2.5B | $2.8B |
| Q4 25 | 0.31× | — | ||
| Q3 25 | 0.38× | — | ||
| Q2 25 | 0.38× | — | ||
| Q1 25 | 0.61× | — | ||
| Q4 24 | 0.47× | — | ||
| Q3 24 | 0.48× | — | ||
| Q2 24 | 0.50× | — | ||
| Q1 24 | 0.51× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $82.4M | $190.4M |
| Free Cash FlowOCF − Capex | $50.2M | $105.2M |
| FCF MarginFCF / Revenue | 13.9% | 17.1% |
| Capex IntensityCapex / Revenue | 8.9% | 13.9% |
| Cash ConversionOCF / Net Profit | 2.67× | — |
| TTM Free Cash FlowTrailing 4 quarters | $173.3M | $287.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $82.4M | $190.4M | ||
| Q3 25 | $85.1M | $167.1M | ||
| Q2 25 | $62.9M | $99.8M | ||
| Q1 25 | $24.0M | $145.8M | ||
| Q4 24 | $78.7M | $127.3M | ||
| Q3 24 | $51.0M | $104.7M | ||
| Q2 24 | $43.4M | $74.8M | ||
| Q1 24 | $10.0M | $73.6M |
| Q4 25 | $50.2M | $105.2M | ||
| Q3 25 | $62.2M | $82.5M | ||
| Q2 25 | $47.8M | $39.9M | ||
| Q1 25 | $13.2M | $59.9M | ||
| Q4 24 | $68.3M | $54.2M | ||
| Q3 24 | $32.8M | $54.5M | ||
| Q2 24 | $31.2M | $45.2M | ||
| Q1 24 | $3.6M | $41.5M |
| Q4 25 | 13.9% | 17.1% | ||
| Q3 25 | 17.4% | 14.7% | ||
| Q2 25 | 13.6% | 7.8% | ||
| Q1 25 | 4.2% | 12.5% | ||
| Q4 24 | 21.2% | 11.8% | ||
| Q3 24 | 10.3% | 12.7% | ||
| Q2 24 | 9.8% | 11.3% | ||
| Q1 24 | 1.2% | 11.0% |
| Q4 25 | 8.9% | 13.9% | ||
| Q3 25 | 6.4% | 15.1% | ||
| Q2 25 | 4.3% | 11.7% | ||
| Q1 25 | 3.4% | 17.9% | ||
| Q4 24 | 3.2% | 15.9% | ||
| Q3 24 | 5.7% | 11.7% | ||
| Q2 24 | 3.8% | 7.4% | ||
| Q1 24 | 2.2% | 8.5% |
| Q4 25 | 2.67× | — | ||
| Q3 25 | 3.18× | — | ||
| Q2 25 | 2.32× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.41× | — | ||
| Q3 24 | 1.55× | — | ||
| Q2 24 | 2.65× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LIVN
| Other | $169.4M | 47% |
| Neuromodulation Segment | $119.7M | 33% |
| Cardiopulmonary Segment | $71.8M | 20% |
NET
| Sales Channel Directly To Consumer | $438.5M | 71% |
| Sales Channel Through Intermediary | $176.0M | 29% |
